A Study of the Long-term Safety and Tolerability and the Long-term Effectiveness of Extended-release Oral Paliperidone in Patients Diagnosed With Schizophrenia
CompletedNCT00210769
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Schizophrenia
Start: 2004-01-31End: 2005-12-31Updated: 2011-05-18